CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 143 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,020,315 | -13.9% | 87,281 | -1.1% | 0.00% | -20.0% |
| Q2 2023 | $1,185,704 | -35.1% | 88,222 | -19.9% | 0.01% | -37.5% |
| Q1 2023 | $1,826,668 | -23.1% | 110,173 | -13.7% | 0.01% | -33.3% |
| Q4 2022 | $2,374,011 | +30.7% | 127,635 | -9.8% | 0.01% | +33.3% |
| Q3 2022 | $1,816,000 | -29.5% | 141,542 | -61.5% | 0.01% | -30.8% |
| Q2 2022 | $2,577,000 | +31.5% | 367,634 | +55.5% | 0.01% | +62.5% |
| Q1 2022 | $1,960,000 | +0.9% | 236,475 | -17.6% | 0.01% | +14.3% |
| Q4 2021 | $1,942,000 | +58.7% | 286,845 | +24.2% | 0.01% | +16.7% |
| Q3 2021 | $1,224,000 | +22.5% | 230,965 | +32.9% | 0.01% | +50.0% |
| Q2 2021 | $999,000 | -17.4% | 173,785 | -52.0% | 0.00% | -20.0% |
| Q4 2020 | $1,209,000 | +4.8% | 362,065 | -6.8% | 0.01% | 0.0% |
| Q3 2020 | $1,154,000 | -47.4% | 388,385 | -18.2% | 0.01% | -54.5% |
| Q2 2020 | $2,194,000 | +80.9% | 474,870 | +50.7% | 0.01% | +37.5% |
| Q1 2020 | $1,213,000 | +203.2% | 315,005 | +195.6% | 0.01% | +300.0% |
| Q4 2019 | $400,000 | -27.0% | 106,560 | +3.2% | 0.00% | -33.3% |
| Q3 2019 | $548,000 | +50.1% | 103,210 | +8.7% | 0.00% | +50.0% |
| Q2 2019 | $365,000 | +67.4% | 94,960 | +122.4% | 0.00% | +100.0% |
| Q1 2019 | $218,000 | +165.9% | 42,700 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $82,000 | -49.4% | 42,700 | -0.5% | 0.00% | 0.0% |
| Q3 2018 | $162,000 | +205.7% | 42,900 | +152.9% | 0.00% | – |
| Q2 2018 | $53,000 | – | 16,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,378,584 | $3,116,000 | 2.30% |
| TANAKA CAPITAL MANAGEMENT INC | 147,993 | $298,000 | 0.90% |
| SOPHROSYNE CAPITAL LLC | 282,500 | $638,000 | 0.56% |
| Ghost Tree Capital, LLC | 200,000 | $452,000 | 0.27% |
| Orbimed Advisors | 1,895,000 | $4,283,000 | 0.05% |
| Financial Architects, Inc | 30,000 | $68,000 | 0.04% |
| Cowen Prime Services LLC | 43,550 | $98,000 | 0.04% |
| Rotella Capital Management, Inc. | 12,300 | $28,000 | 0.03% |
| FEDERATED HERMES, INC. | 3,267,000 | $7,384,000 | 0.02% |
| Baker Brothers Advisors | 569,853 | $1,288,000 | 0.02% |